• NIH/NCI R01CA20416 (4/01/16-3/31/21; a collaboration between the Zeglis Laboratory and the Lewis Laboratory at Memorial Sloan Kettering Cancer Center) The Clinical PET Imaging of Metastatic Breast Cancer with Site-Specifically Labeled 89Zr-Trastuzumab

  • NIH/NCI U01CA221046 (4/01/18-3/31/23; a collaboration between the Zeglis Laboratory and the Lewis Laboratory at Memorial Sloan Kettering Cancer Center) Pretargeted Clinical Imaging of CA19.9 in Pancreatic Cancer

  • NIH/NCI U01CA221046 (7/09/19-6/30/24; a collaboration between the Zeglis Laboratory and the Zheng Laboratory at Hunter College) Novel Reagents for Rapid and Stable Thiol-Based Bioconjugations

  • NIH/NIBIB R21EB030275 (6/01/20-5/31/22; a collaboration between the Zeglis Laboratory and the Qiu Laboratory at Hunter College) A PET Radiotracer for the Diagnostic and Theranostic Imaging of Lyme Disease

  • NIH/NCI R01CA244327 (7/01/20-6/30/25; a collaboration between the Zeglis Laboratory and the Bournazos Laboratory at Rockefeller University) Novel Transgenic Mouse Models Addressing Outstanding Translational Barriers in Antibody-Based Therapeutics

The Zeglis Laboratory is also grateful for the support of the Tow Foundation (GLDR), the Academy of Finland (OMK), and the National Science Foundation (DM) for generous training awards.

 

The Zeglis Laboratory is supported by the following awards from the National Institutes of Health: